Neoadjuvant chemotherapy for advanced epithelial ovarian cancer. Who really benefits?
Aust N Z J Obstet Gynaecol
.
2017 Dec;57(6):585-587.
doi: 10.1111/ajo.12737.
Author
Neville F Hacker
1
Affiliation
1
Gynaecological Cancer Centre, Royal Hospital for Women, University of New South Wales, Sydney, Australia.
PMID:
29210052
DOI:
10.1111/ajo.12737
No abstract available
Publication types
Editorial
Comment
MeSH terms
Carcinoma, Ovarian Epithelial*
Chemotherapy, Adjuvant
Cytoreduction Surgical Procedures
Female
Humans
Neoadjuvant Therapy
Neoplasms, Glandular and Epithelial*